These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 28064277

  • 1. Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells Is Associated with Modulation of Several Transforming Growth Factor-β Family Members.
    Høj Thomsen L, Fog-Tonnesen M, Nielsen Fink L, Norlin J, de Vinuesa AG, Krarup Hansen T, de Heer E, Ten Dijke P, Rosendahl A.
    Nephron; 2017; 135(4):291-306. PubMed ID: 28064277
    [Abstract] [Full Text] [Related]

  • 2. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
    Loeffler I, Liebisch M, Allert S, Kunisch E, Kinne RW, Wolf G.
    Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
    [Abstract] [Full Text] [Related]

  • 3. Disparate phospho-Smad2 levels in advanced type 2 diabetes patients with diabetic nephropathy and early experimental db/db mouse model.
    Thomsen LH, Fog-Tonnesen M, Nielsen Fink L, Norlin J, García de Vinuesa A, Hansen TK, de Heer E, Ten Dijke P, Rosendahl A.
    Ren Fail; 2017 Nov; 39(1):629-642. PubMed ID: 28805484
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.
    Lin S, Yu L, Ni Y, He L, Weng X, Lu X, Zhang C.
    Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A, Speletas M, Leandersson K, Ivars F, Sideras P.
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [Abstract] [Full Text] [Related]

  • 6. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway.
    Zeng Y, Feng Z, Liao Y, Yang M, Bai Y, He Z.
    Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506
    [Abstract] [Full Text] [Related]

  • 7. Imperatorin ameliorates kidney injury in diabetic mice by regulating the TGF-β/Smad2/3 signaling axis, epithelial-to-mesenchymal transition, and renal inflammation.
    Kundu S, Ghosh A, Yadav KS, Mugale MN, Sahu BD.
    Eur J Pharmacol; 2024 Jan 15; 963():176250. PubMed ID: 38092315
    [Abstract] [Full Text] [Related]

  • 8. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
    Wang A, Ziyadeh FN, Lee EY, Pyagay PE, Sung SH, Sheardown SA, Laping NJ, Chen S.
    Am J Physiol Renal Physiol; 2007 Nov 15; 293(5):F1657-65. PubMed ID: 17804483
    [Abstract] [Full Text] [Related]

  • 9. A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling.
    He X, Cheng R, Huang C, Takahashi Y, Yang Y, Benyajati S, Chen Y, Zhang XA, Ma JX.
    Signal Transduct Target Ther; 2020 Apr 29; 5(1):45. PubMed ID: 32345960
    [Abstract] [Full Text] [Related]

  • 10. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
    Okazaki Y, Yamasaki Y, Uchida HA, Okamoto K, Satoh M, Maruyama K, Maeshima Y, Sugiyama H, Sugaya T, Kashihara N, Makino H.
    Clin Exp Nephrol; 2007 Mar 29; 11(1):77-87. PubMed ID: 17385003
    [Abstract] [Full Text] [Related]

  • 11. Repression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions.
    Park JT, Kato M, Lanting L, Castro N, Nam BY, Wang M, Kang SW, Natarajan R.
    Am J Physiol Renal Physiol; 2014 Dec 15; 307(12):F1390-403. PubMed ID: 25354942
    [Abstract] [Full Text] [Related]

  • 12. The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats.
    Hill C, Flyvbjerg A, Grønbaek H, Petrik J, Hill DJ, Thomas CR, Sheppard MC, Logan A.
    Endocrinology; 2000 Mar 15; 141(3):1196-208. PubMed ID: 10698197
    [Abstract] [Full Text] [Related]

  • 13. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V, Droguett A, Valderrama G, Burgos ME, Carpio D, Kerr B, Ruiz-Ortega M, Egido J, Mezzano S.
    Am J Physiol Renal Physiol; 2015 Sep 15; 309(6):F559-68. PubMed ID: 26155842
    [Abstract] [Full Text] [Related]

  • 14. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
    Wang Y, Lin C, Ren Q, Liu Y, Yang X.
    Int J Clin Exp Pathol; 2015 Sep 15; 8(6):6828-34. PubMed ID: 26261569
    [Abstract] [Full Text] [Related]

  • 15. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway.
    Sutariya B, Saraf M.
    J Ethnopharmacol; 2017 Feb 23; 198():432-443. PubMed ID: 28111218
    [Abstract] [Full Text] [Related]

  • 16. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes.
    Huang C, Kim Y, Caramori ML, Fish AJ, Rich SS, Miller ME, Russell GB, Mauer M.
    Diabetes; 2002 Dec 23; 51(12):3577-81. PubMed ID: 12453917
    [Abstract] [Full Text] [Related]

  • 17. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
    Moon JA, Kim HT, Cho IS, Sheen YY, Kim DK.
    Kidney Int; 2006 Oct 23; 70(7):1234-43. PubMed ID: 16929250
    [Abstract] [Full Text] [Related]

  • 18. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
    Liu L, Wang Y, Yan R, Liang L, Zhou X, Liu H, Zhang X, Mao Y, Peng W, Xiao Y, Zhang F, Liu L, Shi M, Guo B.
    Life Sci; 2019 Dec 01; 238():116957. PubMed ID: 31655195
    [Abstract] [Full Text] [Related]

  • 19. Reduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathway.
    Wang T, Chen SS, Chen R, Yu DM, Yu P.
    Int J Clin Exp Pathol; 2015 Dec 01; 8(3):2321-33. PubMed ID: 26045739
    [Abstract] [Full Text] [Related]

  • 20. Role of IGFBP7 in Diabetic Nephropathy: TGF-β1 Induces IGFBP7 via Smad2/4 in Human Renal Proximal Tubular Epithelial Cells.
    Watanabe J, Takiyama Y, Honjyo J, Makino Y, Fujita Y, Tateno M, Haneda M.
    PLoS One; 2016 Dec 01; 11(3):e0150897. PubMed ID: 26974954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.